As of December 31, 2024, the company had available cash reserves and short-term investments of $120.6M and net working capital of $118.8M. The company has no long-term debt facilities.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPIX:
- ESSA Pharma Inc. (EPIX) Q1 Earnings Cheat Sheet
- ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky LLP Before March 25, 2025 to Discuss Your Rights – EPIX
- ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability
- ESSA Pharma Inc. Reports Strategic Shift Amid Losses
- Essa Pharma reports Q4 EPS (14c), consensus (27c)